A−90/100
Graded #2Partner
Eden
High-disclosure, high-oversight compounded program with the cleanest verification signals.
Visit Eden ↗Partner — we may earn a commission, at no cost to you. It never changes the grade.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
Factor breakdown
Each of the six graded dimensions. See the methodology.
Cost value85/100
Dose & formulation86/100
Clinical oversight95/100
Labs & monitoring92/100
Fulfillment93/100
Contract terms90/100
Strengths
- High verification confidence
- Nationwide
- Both molecules
Where it loses points
- Premium pricing
- Compounded only
Bottom line — Grade A−
Best for: People who weight clinical oversight and transparency over the lowest price.
Pricing/verification reflect Eden's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.